Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Taiichiro, Imanishi"'
Publikováno v:
Acta Neuropsychiatrica. 28:327-336
ObjectiveAsenapine is an atypical antipsychotic that is currently available for the treatment of schizophrenia and bipolar I disorder. Although the atypical antipsychotics clozapine and olanzapine are effective for depression and anxiety in schizophr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a312dde8ebfd5b416d49ba04729f474
https://doi.org/10.1017/neu.2016.17
https://doi.org/10.1017/neu.2016.17
Publikováno v:
Neuropharmacology. 62:2278-2287
Mirtazapine, an antidepressant, antagonizes α(2)-adrenergic autoreceptors and heteroreceptors, which leads to enhanced noradrenergic and serotonergic transmission without inhibiting monoamine transporters. Using a microdialysis technique, we investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b5a331466c6e94ff2d14b72844e291a
https://doi.org/10.1016/j.neuropharm.2012.01.024
https://doi.org/10.1016/j.neuropharm.2012.01.024
Publikováno v:
Brain Research. 1067:164-169
We have previously shown that chronic treatment with selective serotonin reuptake inhibitors (SSRIs), fluvoxamine and paroxetine, attenuated m-chlorophenylpiperazine (mCPP)-induced hypolocomotion in rats. The effect of these SSRIs on the response to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90bf46e24cbb239ceea0e12ca5799b90
https://doi.org/10.1016/j.brainres.2005.10.075
https://doi.org/10.1016/j.brainres.2005.10.075
Publikováno v:
European Journal of Pharmacology. 454:183-188
Paroxetine, a selective serotonin reuptake inhibitor, shows relatively high affinity for muscarinic acetylcholine receptors compared to other selective serotonin reuptake inhibitors. To determine whether paroxetine has anticholinergic effects in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff57e097f0f6282247f3838ee6dac3dd
https://doi.org/10.1016/s0014-2999(02)02557-8
https://doi.org/10.1016/s0014-2999(02)02557-8
Publikováno v:
Folia Pharmacologica Japonica. 118:403-410
Fluvoxamine, a selective serotonin reuptake inhibitor, is frequently used along with benzodiazepine anxiolytics in clinics. In this study, the effects of fluvoxamine on the anxiolytic effects as well as adverse effects of benzodiazepines were examine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9275bf0ff441850f72592d775e0e9aab
https://doi.org/10.1254/fpj.118.403
https://doi.org/10.1254/fpj.118.403
Publikováno v:
Japanese Journal of Pharmacology. 85:327-330
We examined the effects of two noradrenergic tricyclic antidepressants and two selective serotonin re-uptake inhibitors in the tail suspension test, with a suspension period of 30 min instead of the usual 10 min. Within the first 10 min, desipramine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf3ff8dade00780de1c16765b810191b
https://doi.org/10.1254/jjp.85.327
https://doi.org/10.1254/jjp.85.327
Publikováno v:
Neuroscience Letters. 193:81-84
The effects of ofloxacin (OFLX) and its isomers, levofloxacin (LVFX) and DR-3354, on the γ-aminobutyric acid (GABA)-induced Cl − current in acutely dissociated rat hippocampal CAI neurons were investigated using nystatin perforated patch recording
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eef76880457829e09b3100a11aedfed5
https://doi.org/10.1016/0304-3940(95)11670-r
https://doi.org/10.1016/0304-3940(95)11670-r
Publikováno v:
Japanese Journal of Pharmacology. 68:71-75
The effect of fluvoxamine, a selective serotonin (5-HT) reuptake inhibitor, was studied in the forced-swimming test, a model of depression, in mice. Fluvoxamine at 60 mg/kg, p.o. significantly decreased the immobility time in the forced-swimming test
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f36baed8a53005ad76b002208741ceb5
https://doi.org/10.1254/jjp.68.71
https://doi.org/10.1254/jjp.68.71
Autor:
Koichi Kitamura, Tsukasa Koyama, Fumikazu Yokoyama, Nobukazu Kakui, Miki Yamauchi, Takeshi Inoue, Taiichiro Imanishi
Publikováno v:
Pharmacology, biochemistry, and behavior. 92(3)
Mirtazapine is an antidepressant with a unique mechanism of action and has been categorized as a Noradrenergic and Specific Serotonergic Antidepressant (NaSSA). Although numerous clinical trials suggested the usefulness of mirtazapine for not only ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3704e82d65c096f401d09981a6b2ee38
https://pubmed.ncbi.nlm.nih.gov/19167420
https://pubmed.ncbi.nlm.nih.gov/19167420
Publikováno v:
Pharmacology, biochemistry, and behavior. 87(1)
Previous studies demonstrated that rats allowed access to running wheel with food restriction schedules run excessively. This hyperactivity consisted of a pre-feeding activity (an increase in running activity before the feeding time, also termed food
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cfa1e09d2d32fe3152f7f956621a37b
https://pubmed.ncbi.nlm.nih.gov/17493672
https://pubmed.ncbi.nlm.nih.gov/17493672